This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Mar;25(3):287-92.

doi: 10.1038/nbt0307-287.

Overhauling clinical trials

Christopher Thomas Scott¹, Monya Baker

Affiliations

PMID: 17344876
DOI: 10.1038/nbt0307-287

Overhauling clinical trials

Christopher Thomas Scott et al. Nat Biotechnol. 2007 Mar.

. 2007 Mar;25(3):287-92.

doi: 10.1038/nbt0307-287.

Authors

Christopher Thomas Scott¹, Monya Baker

Affiliation

¹ Program on Stem Cells in Society, Stanford Center for Biomedical Ethics, Stanford, California, USA. cscott@stanford.edu

PMID: 17344876
DOI: 10.1038/nbt0307-287

No abstract available

PubMed Disclaimer

Similar articles

FDA perspective on clinical trial design for cardiovascular devices.
Chen E, Sapirstein W, Ahn C, Swain J, Zuckerman B. Chen E, et al. Ann Thorac Surg. 2006 Sep;82(3):773-5. doi: 10.1016/j.athoracsur.2006.07.044. Ann Thorac Surg. 2006. PMID: 16928481 No abstract available.
Clinical trial design issues in schizophrenic research.
Casey DE. Casey DE. J Clin Psychiatry. 2001;62 Suppl 9:17-20; discussion 21-2. J Clin Psychiatry. 2001. PMID: 11379826
Industry looks to buck bias in emerging 'adaptive' designs.
Torres C. Torres C. Nat Med. 2010 Jun;16(6):619. doi: 10.1038/nm0610-619a. Nat Med. 2010. PMID: 20526301 No abstract available.
Protocol design.
Wilensky AJ. Wilensky AJ. Epilepsy Res Suppl. 1993;10:107-13. Epilepsy Res Suppl. 1993. PMID: 8251086 Review. No abstract available.
External influences on protocol design.
Spilker B. Spilker B. Epilepsy Res Suppl. 1993;10:115-24. Epilepsy Res Suppl. 1993. PMID: 8251087 Review. No abstract available.

See all similar articles

Cited by

Neuroprotection for ischemic stroke: past, present and future.
Ginsberg MD. Ginsberg MD. Neuropharmacology. 2008 Sep;55(3):363-89. doi: 10.1016/j.neuropharm.2007.12.007. Epub 2008 Mar 4. Neuropharmacology. 2008. PMID: 18308347 Free PMC article. Review.
A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence.
Karalis VD. Karalis VD. J Cardiovasc Dev Dis. 2024 Jun 21;11(7):185. doi: 10.3390/jcdd11070185. J Cardiovasc Dev Dis. 2024. PMID: 39057608 Free PMC article.
Response-adaptive decision-theoretic trial design: operating characteristics and ethics.
Lipsky AM, Lewis RJ. Lipsky AM, et al. Stat Med. 2013 Sep 20;32(21):3752-65. doi: 10.1002/sim.5807. Epub 2013 Apr 4. Stat Med. 2013. PMID: 23558674 Free PMC article.
Randomized Controlled Trials 1: Design.
Curtis BM, Barrett BJ, Parfrey PS. Curtis BM, et al. Methods Mol Biol. 2021;2249:193-211. doi: 10.1007/978-1-0716-1138-8_11. Methods Mol Biol. 2021. PMID: 33871845
Confounding due to changing background risk in adaptively randomized trials.
Lipsky AM, Greenland S. Lipsky AM, et al. Clin Trials. 2011 Aug;8(4):390-7. doi: 10.1177/1740774511406950. Epub 2011 May 24. Clin Trials. 2011. PMID: 21610005 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information